Posterior reversible encephalopathy syndrome (PRES) with immune system activation, VEGF up-regulation, and cerebral amyloid angiopathy

Journal of Computer Assisted Tomography

Volumn 35, Issue 1, 2011, Pages 39-42

  Kofler, Julia ^a   Bartynski, Walter S ^b   Reynolds, Thomas Q ^a   Lieberman, Frank S ^a   Murdoch, Geoffrey H ^a   Hamilton, Ronald L ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

Author keywords

cerebral amyloid angiopathy; Posterior reversible encephalopathy syndrome; vasogenic edema

Indexed keywords

CELL ENGINEERING; CHEMICAL ACTIVATION; ENDOTHELIAL CELLS; GLYCOPROTEINS; NEURODEGENERATIVE DISEASES; T-CELLS;

BLOOD FLOW; CELL TRAFFICKING; CEREBRAL AMYLOID ANGIOPATHY; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; RESPIRATORY TRACT INFECTIONS; SYSTEM ACTIVATION; UP-REGULATION; UPPER RESPIRATORY TRACT; VASCULAR ENDOTHELIAL GROWTH FACTOR; VASOGENIC EDEMA;

IMMUNE SYSTEM;

ACICLOVIR; AMYLOID BETA PROTEIN; ANTIBIOTIC AGENT; ANTIVIRUS AGENT; CEFEPIME; DEXAMETHASONE; ETIRACETAM; PHENYTOIN; PROPOFOL; VANCOMYCIN; VASCULOTROPIN;

AGED; ANTIBIOTIC THERAPY; ANTIHYPERTENSIVE THERAPY; ANTIVIRAL THERAPY; ARTICLE; B CELL LYMPHOMA; BONE MARROW SUPPRESSION; BRAIN ANGIOGRAPHY; BRAIN BIOPSY; BRAIN BLOOD FLOW; BRAIN VASCULITIS; CANCER CHEMOTHERAPY; CASE REPORT; CELL ACTIVATION; CEREBROSPINAL FLUID ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONFUSION; ELECTROENCEPHALOGRAPHY; ENDOTHELIUM CELL; FLOW CYTOMETRY; FRONTAL LOBE; HEADACHE; HOSPITAL READMISSION; HUMAN; HUMAN CELL; IMMUNE SYSTEM; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE MIGRATION; LYMPHOMA; MALE; MEDICAL HISTORY; NEUROIMAGING; PLEOCYTOSIS; POSITRON EMISSION TOMOGRAPHY; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; PROTEIN EXPRESSION; SLURRED SPEECH; T LYMPHOCYTE; UPREGULATION; VASCULAR AMYLOIDOSIS; VIRAL UPPER RESPIRATORY TRACT INFECTION; WHITE MATTER;

EID: 79551538256     PISSN: 03638715     EISSN: None     Source Type: Journal    
DOI: 10.1097/RCT.0b013e3181f31917     Document Type: Article

References (19)

1. Bartynski WS. Posterior reversible encephalopathy syndrome; Part 1: fundamental imaging and clinical features. AJNR Am J Neuroradiol. 2008;29:1036-1042.
2. Lee VH, Wijdicks EF, Manno EM, et al. Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Arch Neurol. 2008;65:205-210.
3. Bartynski WS. Posterior reversible encephalopathy syndrome; Part 2: controversies surrounding pathophysiology of vasogenic edema. AJNR Am J Neuroradiol. 2008;29:1043-1049.
4. Horbinski C, Bartynski WS, Carson-Walter E, et al. Reversible encephalopathy after cardiac transplantation: histologic evidence of endothelial activation, T-cell specific trafficking, and vascular endothelial growth factor expression. AJNR Am J Neuroradiol. 2009;30:588-590.
5. Bartynski WS, Upadhyaya AR, Boardman JF. Posterior reversible encephalopathy syndrome and cerebral vasculopathy associated with influenza A infection: report of a case and review of the literature. J Comput Assist Tomogr. 2009;33:917-922.
6. Imaoka K, Kobayashi S, Fujihara S, et al. Leukoencephalopathy with cerebral amyloid angiopathy: a semiquantitative and morphometric study. J Neurol. 1999;246:661-666.
7. Maia LF, Mackenzie IR, Feldman HH. Clinical phenotypes of cerebral amyloid angiopathy. J Neurol Sci. 2007;257:23-30.
8. Iadecola C. Cerebrovascular effects of amyloid-beta peptides: mechanisms and implications for Alzheimer's dementia. Cell Mol Neurobiol. 2003;23:681-689.
9. Smith EE, Greenberg SM. Beta-amyloid, blood vessels, and brain function. Stroke. 2009;40:2601-2606.
10. Chung YA, OJ H, Kim JY, et al. Hypoperfusion and ischemia in cerebral amyloid angiopathy documented by 99mTc-ECD brain perfusion SPECT. J Nucl Med. 2009;50:1969-1974.
11. Niwa K, Kazama K, Younkin L, et al. Cerebrovascular autoregulation is profoundly impaired in mice overexpressing amyloid precursor protein. Am J Physiol Heart Circ Physiol. 2002;283:H315-H323.
12. Sarazin M, Amarenco P, Mikol J, et al. Reversible leukoencephalopathy in cerebral amyloid angiopathy presenting as subacute dementia. Eur J Neurol. 2002;9:353-358.
13. Eng JA, Frosch MP, Choi K, et al. Clinical manifestations of cerebral amyloid angiopathyYrelated inflammation. Ann Neurol. 2004;55:250-256.
14. Kinnecom C, Lev MH, Wendell L, et al. Course of cerebral amyloid angiopathyYrelated inflammation. Neurology. 2007;68:1411-1416.
15. Cano LM, Martinez-Yelamos S, Majos C, et al. Reversible acute leukoencephalopathy as a form of presentation in cerebral amyloid angiopathy. J Neurol Sci. 2010;288:190-193.
16. Machida K, Tojo K, Naito KS, et al. Cortical petechial hemorrhage, subarachnoid hemorrhage and corticosteroid-responsive leukoencephalopathy in a patient with cerebral amyloid angiopathy. Amyloid. 2008;15:60-64.
17. McHugh JC, Ryan AM, Lynch T, et al. Steroid-responsive recurrent encephalopathy in a patient with cerebral amyloid angiopathy. Cerebrovasc Dis. 2007;23:66-69.
18. Harkness KA, Coles A, Pohl U, et al. Rapidly reversible dementia in cerebral amyloid inflammatory vasculopathy. Eur J Neurol. 2004;11:59-62.
19. Oh U, Gupta R, Krakauer JW, et al. Reversible leukoencephalopathy associated with cerebral amyloid angiopathy. Neurology. 2004; 62:494-497.